Listed by the USPTO as NGUYEN, NGOC-ANH THI
Tech Center 1600 • Art Units: 1615 1624 1631 1655
This examiner grants 30% of resolved cases
NGUYEN, NGOC-ANH THI is a USPTO patent examiner in tech center 1600 and art unit 1615. The record contains 66 resolved cases and a 30.3% allowance rate. Median time to allowance is 1264 days. Interview lift is 50.0%, substantially above the allowance rate in this profile. The smaller resolved-case record makes individual file review especially important, while the interview figure supports active consideration of examiner engagement.
The leading companies are Bristol-Myers Squibb Company, The Procter & Gamble Company, and ModernaTX Inc. The principal firms are FOLEY & LARDNER LLP, KPPB LLP, and BACON & THOMAS, PLLC. The 1264-day median calls for early attention to prosecution sequencing, evidence, and claim amendments where applicants face a demanding path to allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17753657 | PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS | Final Rejection | BRISTOL-MYERS SQUIBB COMPANY |
| 17792554 | METHODS OF PREPARING LIPID NANOPARTICLES | Final Rejection | ModernaTX, Inc. |
| 18081915 | COSMETIC COMPOSITION COMPRISING VITAMIN B3 COMPOUND AND LAUROYL LYSINE | Final Rejection | The Procter & Gamble Company |
| 17490877 | COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS | Final Rejection | Genentech, Inc. |
| 18486054 | Systems and Methods for Assessment of Lipid Membrane-Associated Molecule Kinetics, Dynamics, and Interactions | Non-Final OA | California Institute of Technology |
| 18853279 | IMPROVEMENT OF THE WATER RESISTANCE OF COSMETIC COMPOSITIONS COMPRISING UV FILTERS | Non-Final OA | DSM IP Assets B.V. |
| 17641124 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES | Final Rejection | Purdue Research Foundation |
| 17769907 | CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS | Final Rejection | University of Virginia Patent Foundation |
| 18704688 | COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS | Non-Final OA | L'OREAL |
| 19110497 | POWDER COSMETIC PREPARATION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 17433289 | TRANSDERMAL PATCH | Final Rejection | HISAMITSU PHARMACEUTICAL CO., INC. |
| 18281115 | USE OF TAMOXIFEN AND RELATED COMPOUNDS TO REDUCE BREAST IMPLANT CAPSULE FORMATION AND CAPSULAR CONTRACTURE | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy30.3% of resolved applications examined by Ngoc-Anh Thi Nguyen were allowed (66 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +50.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ngoc-Anh Thi Nguyen took 1,264 days on average from filing to allowance.
Ngoc-Anh Thi Nguyen examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
